TRANSMURAL HEALING IN PATIENTS WITH CROHN'S DISEASE TREATED WITH ANTI-TNF THERAPY

被引：0
|
作者：
Pastaud, Clement
Hordonneau, Constance
Lambert, Celine
Vignette, Jeanne
Pereira, Bruno
Buisson, Anthony
机构：
来源：
GASTROENTEROLOGY | 2020年 / 158卷 / 06期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
Mo1861
引用
收藏
页码：S953 / S954
页数：2
相关论文
共 50 条
  • [41] Anti-TNF antibody therapy in Crohn's disease: the risk of a switch
    Ricart, Elena
    Ordas, Ingrid
    Panes, Julian
    GUT, 2012, 61 (02) : 169 - 170
  • [42] HEMOGLOBIN AND FERRITIN VALUES ARE ASSOCIATED WITH INCREASED RATE OF MUCOSAL HEALING IN PATIENTS WITH CROHN'S DISEASE TREATED WITH ANTI-TNF ALPHA
    Mendolaro, M.
    Cappello, M.
    Viola, A.
    Cilluffo, M. G.
    Vita, G.
    Peralta, S.
    Calvaruso, V
    Craxi, A.
    DIGESTIVE AND LIVER DISEASE, 2016, 48 : E158 - E159
  • [43] THE INCIDENCE OF CARDIOVASCULAR EVENTS IN PATIENTS WITH CROHN'S DISEASE TREATED WITH VEDOLIZUMAB AND ANTI-TNF THERAPIES
    Cross, Raymond K.
    Osterman, Mark T.
    Panaccione, Remo
    Afzali, Anita
    Song, Xue
    Shi, Nianwen
    Ding, Yao
    Wang, Anthony
    GASTROENTEROLOGY, 2017, 152 (05) : S577 - S578
  • [44] The Impact of Setons on Perianal Fistula Outcomes in Patients With Crohn's Disease Treated With Anti-TNF Therapy: A Multicentre Study
    Mccurdy, Jeffrey
    Munir, Javeria
    Parlow, Simon
    Sambhi, Gagan
    Reid, Jacqueline
    Yanofsky, Russell
    Alenezi, Talal
    Meserve, Joseph
    Yeh, Kuan-Hung
    Becker, Brenda
    Lahijanian, Zubin
    Eddin, Anas Hussam
    Mallick, Ranjeeta
    Ramsay, Tim
    Rosenfeld, Greg
    Bessissow, Ali
    Bessissow, Talat
    Jairath, Vipul
    Bruining, David H.
    Macdonald, Blair
    Singh, Siddharth
    Canadian IBD Res Consortium CIRC
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2025,
  • [45] REASSESSMENT OF CROHN'S DISEASE TREATED WITH 12 MONTHS OF ANTI-TNF THERAPY: A TERTIARY CENTRE EXPERIENCE
    Dart, R.
    Griffin, N.
    Taylor, K.
    Duncan, J.
    Sastrillo, M.
    Anderson, S.
    Sanderson, J.
    Irving, P. M.
    GUT, 2012, 61 : A397 - A397
  • [46] Factors Predicting a Favorable Disease Course Without Anti-TNF Therapy in Crohn's Disease Patients
    Inokuchi, Toshihiro
    Hiraoka, Sakiko
    Yasutomi, Eriko
    Oka, Shohei
    Yamasaki, Yasushi
    Kinugasa, Hideaki
    Takahara, Masahiro
    Kawano, Seiji
    Harada, Keita
    Okada, Hiroyuki
    Kato, Jun
    ACTA MEDICA OKAYAMA, 2020, 74 (04) : 265 - 274
  • [47] Rates of Anti-TNF Drug Persistence in Patients with Crohn's Disease
    Alexa, Silfen
    Tina, Rodriguez
    Jordan, Karpin
    Cindy, Traboulsi
    Victoria, Rai
    David, Rubin
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2020, 115 : S9 - S9
  • [48] Efficacy of anti-TNFα drugs in patients with stricturing Crohn's disease
    D'Amico, Ferdinando
    Pugliese, Nicola
    Peyrin-Biroulet, Laurent
    Danese, Silvio
    EXPERT REVIEW OF GASTROENTEROLOGY & HEPATOLOGY, 2020, 14 (05) : 347 - 353
  • [49] Anti-TNF Therapy Is Associated with Decreased Imaging and Radiation Exposure in Patients with Crohn's Disease
    Patil, Seema A.
    Rustgi, Ankur
    Quezada, Sandra M.
    Flasar, Mark H.
    Vandermeer, Fauzia
    Cross, Raymond K.
    INFLAMMATORY BOWEL DISEASES, 2013, 19 (01) : 92 - 98
  • [50] Preventing TB in patients with Crohn's disease needing infliximab or other anti-TNF therapy
    Rampton, DS
    GUT, 2005, 54 (10) : 1360 - 1362
12345